Cargando…

A Pilot Study of Fluorodeoxyglucose Positron Emission Tomography Findings in Patients with Phenylketonuria before and during Sapropterin Supplementation

BACKGROUND AND PURPOSE: PET scanning with fluorodeoxyglucose (FDG-PET) is a non-invasive method that measures regional glucose metabolic rate. Phenylalanine (Phe) and its metabolites appear to impair several aspects of brain energy metabolism. 1) To evaluate brain glucose metabolism with FDG-PET ima...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ficicioglu, Can, Dubroff, Jacob G, Thomas, Nina, Gallagher, Paul R, Burfield, Jessica, Hussa, Christie, Randall, Rebecca, Zhuang, Hongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722466/ https://www.ncbi.nlm.nih.gov/pubmed/23894238 http://dx.doi.org/10.3988/jcn.2013.9.3.151

Ejemplares similares

New era in treatment for phenylketonuria: Pharmacologic therapy with sapropterin dihydrochloride
por: Harding, Cary O
Publicado: (2010)

Sapropterin for phenylketonuria: A Japanese post‐marketing surveillance study
por: Tamura, Mina, et al.
Publicado: (2022)

Longitudinal quality of life analysis in a phenylketonuria cohort provided sapropterin dihydrochloride
por: Douglas, Teresa D, et al.
Publicado: (2013)

A Prospective Population Pharmacokinetic Analysis of Sapropterin Dihydrochloride in Infants and Young Children with Phenylketonuria
por: Qi, Yulan, et al.
Publicado: (2014)

Pretreatment cognitive and neural differences between sapropterin dihydrochloride responders and non-responders with phenylketonuria
por: Hawks, Zoë, et al.
Publicado: (2017)

Efficacy and safety of sapropterin dihydrochloride in patients with phenylketonuria: A meta‐analysis of randomized controlled trials
por: Qu, Jinghan, et al.
Publicado: (2019)

First Japanese case of maternal phenylketonuria treated with sapropterin dihydrochloride and the normal growth and development of the child
por: Nyuzuki, Hiromi, et al.
Publicado: (2019)

Long-term efficacy and safety of sapropterin in patients who initiated sapropterin at < 4 years of age with phenylketonuria: results of the 3-year extension of the SPARK open-label, multicentre, randomised phase IIIb trial
por: Muntau, Ania C., et al.
Publicado: (2021)

Long-term preservation of intellectual functioning in sapropterin-treated infants and young children with phenylketonuria: A seven-year analysis
por: Waisbren, Susan, et al.
Publicado: (2021)

Impact on Diet Quality and Burden of Care in Sapropterin Dihydrochloride Use in Children with Phenylketonuria: A 6 Month Follow-Up Report
por: Gama, Maria Inês, et al.
Publicado: (2023)

Hepatic Pseudolymphoma with Fluorodeoxyglucose Uptake on Positron Emission Tomography
por: Suzumura, Kazuhiro, et al.
Publicado: (2017)

Fluorodeoxyglucose positron emission tomography in pyrexia of unknown origin
por: Angamuthu, Meivel, et al.
Publicado: (2020)

Fluorodeoxyglucose-positron emission tomography in carcinoma nasopharynx: Can we predict outcomes and tailor therapy based on postradiotherapy fluorodeoxyglucose-positron emission tomography?
por: Laskar, Sarbani Ghosh, et al.
Publicado: (2016)

Sapropterin Dihydrochloride Mixed With Common Foods and Beverages
por: Jurecki, Elaina R., et al.
Publicado: (2014)

Diagnosis of prostatitis by 18-F-fluorodeoxyglucose positron emission tomography
por: Ho, Thien Anh, et al.
Publicado: (2009)

Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in Disseminated Cryptococcosis
por: Tripathy, Sarthak, et al.
Publicado: (2017)

Pulmonary “Finger-in-glove” Sign on Fluorodeoxyglucose-positron Emission Tomography
por: Yanagisawa, Satoru, et al.
Publicado: (2019)

Thoracic positron emission tomography: (18)F-fluorodeoxyglucose and beyond
por: Jaykel, Timothy J., et al.
Publicado: (2020)

Neurolymphomatosis detected by (18)F‐fluorodeoxyglucose‐positron emission tomography
por: Hori, Yoshikazu, et al.
Publicado: (2020)

Fluorodeoxyglucose Positron Emission Tomography Imaging in Pneumocystis jiroveci Pneumonia
por: Rathore, Hemant, et al.
Publicado: (2022)

Bilateral Diffuse Fluorodeoxyglucose Uptake in Thyroid Gland Diagnosed by Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
por: Win, Aung Zaw, et al.
Publicado: (2014)

Sapropterin (BH4) Aggravates Autoimmune Encephalomyelitis in Mice
por: Schmitz, Katja, et al.
Publicado: (2021)

Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse
por: Hain, S F, et al.
Publicado: (2000)

Initial evaluation of inflammatory breast cancer with fluorodeoxyglucose positron emission tomography
por: Sager, Sait, et al.
Publicado: (2012)

Risk of Malignancy in Thyroid Incidentalomas Identified by Fluorodeoxyglucose-Positron Emission Tomography
por: Chun, A Reum, et al.
Publicado: (2015)

(18)F-fluorodeoxyglucose positron emission tomography in dementia with Lewy bodies
por: Graff-Radford, Jonathan, et al.
Publicado: (2020)

Gallbladder lymphoma detected by (18)F-fluorodeoxyglucose positron emission tomography
por: So, Alvin, et al.
Publicado: (2020)

Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose
por: Zhu, Jing, et al.
Publicado: (2022)

Radiomics Features of (18)F-Fluorodeoxyglucose Positron-Emission Tomography as a Novel Prognostic Signature in Colorectal Cancer
por: Kang, Jeonghyun, et al.
Publicado: (2021)

The role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the primary staging of rectal cancer
por: Ozis, Salih Erpulat, et al.
Publicado: (2014)

The role of [(18)F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors
por: Kaira, Kyoichi, et al.
Publicado: (2011)

Diagnostic role of fluorodeoxyglucose positron emission tomography-computed tomography in prostate cancer
por: LIU, YIYAN
Publicado: (2014)

The role of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with mycosis fungoides
por: Alanteri, Eiman, et al.
Publicado: (2015)

F-18 fluorodeoxyglucose positron emission tomography for differential diagnosis of pancreatic tumors
por: Yoshioka, Masato, et al.
Publicado: (2015)

Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Various Orbital Malignancies
por: Natarajan, Aravintho, et al.
Publicado: (2018)

Gossypiboma of Axilla: Imaging Pitfalls on Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography
por: Kuruva, Manohar, et al.
Publicado: (2018)

Vascular Imaging With (18)F-Fluorodeoxyglucose Positron Emission Tomography Is Influenced by Hypoxia
por: Joshi, Francis R., et al.
Publicado: (2017)

(18)F-Fluorodeoxyglucose positron emission tomography may not visualize radiation pneumonitis
por: Guo, Meiying, et al.
Publicado: (2019)

F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the infection of heart
por: Kong, Eunjung
Publicado: (2020)

Tracheobronchial Tuberculosis Mimicking Malignancy on Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
por: Yamane, Mayuka, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v35kit2focd5aoouhevqcsm0e0